Literature DB >> 11186123

Melatonin treatment for circadian rhythm sleep disorders.

Y Kamei1, T Hayakawa, J Urata, M Uchiyama, K Shibui, K Kim, Y Kudo, M Okawa.   

Abstract

This study investigated the effects of melatonin administration on circadian rhythm sleep disorders, and aimed to clarify clinical characteristics of melatonin responders. The subjects were 46 patients with circadian rhythm sleep disorders: 30 Delayed Sleep Phase Syndrome (DSPS) and 16 non-24 h sleep-wake syndrome (non-24). Patients took 0.3-1.0 mg of melatonin 5, 3 and 1 h before habitual bedtime. Seventeen patients responded to melatonin (12 DSPS, five non-24). Comparison of clinical background between responders and non-responders revealed that the responders were characterized by short total sleep time and later onset age of clinical symptoms.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11186123     DOI： 10.1046/j.1440-1819.2000.00724.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN： 1323-1316            Impact factor:   5.188


  9 in total

Review 1.  Yeast factories for the production of aromatic compounds: from building blocks to plant secondary metabolites.

Authors:  Miguel Suástegui; Zengyi Shao
Journal:  J Ind Microbiol Biotechnol       Date:  2016-08-31       Impact factor: 3.346

2.  Therapeutics for Circadian Rhythm Sleep Disorders.

Authors:  Ehren R Dodson; Phyllis C Zee
Journal:  Sleep Med Clin       Date:  2010-12

3.  Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  R Robert Auger; Helen J Burgess; Jonathan S Emens; Ludmila V Deriy; Sherene M Thomas; Katherine M Sharkey
Journal:  J Clin Sleep Med       Date:  2015-10-15       Impact factor: 4.062

Review 4.  Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review.

Authors:  Robert L Sack; Dennis Auckley; R Robert Auger; Mary A Carskadon; Kenneth P Wright; Michael V Vitiello; Irina V Zhdanova
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

Review 5.  Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report.

Authors:  Timothy I Morgenthaler; Teofilo Lee-Chiong; Cathy Alessi; Leah Friedman; R Nisha Aurora; Brian Boehlecke; Terry Brown; Andrew L Chesson; Vishesh Kapur; Rama Maganti; Judith Owens; Jeffrey Pancer; Todd J Swick; Rochelle Zak
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

Review 6.  Circadian Rhythm Sleep-Wake Disorders: a Contemporary Review of Neurobiology, Treatment, and Dysregulation in Neurodegenerative Disease.

Authors:  Tyler A Steele; Erik K St Louis; Aleksandar Videnovic; R Robert Auger
Journal:  Neurotherapeutics       Date:  2021-04-12       Impact factor: 7.620

7.  Evaluation of circadian phenotypes utilizing fibroblasts from patients with circadian rhythm sleep disorders.

Authors:  A Hida; Y Ohsawa; S Kitamura; K Nakazaki; N Ayabe; Y Motomura; K Matsui; M Kobayashi; A Usui; Y Inoue; H Kusanagi; Y Kamei; K Mishima
Journal:  Transl Psychiatry       Date:  2017-04-25       Impact factor: 6.222

8.  New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists.

Authors:  Rüdiger Hardeland
Journal:  Neuropsychiatr Dis Treat       Date:  2009-06-10       Impact factor: 2.570

9.  Effect of aripiprazole on non-24-hour sleep-wake rhythm disorder comorbid with major depressive disorder: a case report.

Authors:  Kentaro Matsui; Yoshikazu Takaesu; Takeshi Inoue; Ken Inada; Katsuji Nishimura
Journal:  Neuropsychiatr Dis Treat       Date:  2017-05-19       Impact factor: 2.570
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.